Eli Lilly Aktie
WKN: 858560 / ISIN: US5324571083
|
13.03.2024 21:16:40
|
Eli Lilly Strikes Deal With Amazon Pharmacy To Deliver Prescription Drugs
(RTTNews) - Eli Lilly (LLY) announced that Amazon's (AMZN) Pharmacy subsidiary has agreed to deliver several prescription drugs, including weight loss drug Zepbound, directly to the customers' homes.
Under the agreement, Amazon Pharmacy will deliver prescribed drugs for obesity, diabetes and migraine to the customers who have ordered through Eli Lilly's website, LillyDirect.
"I think it's a wonderful advantage," Frank Cunningham, Eli Lilly's senior vice president of global value and access, said. "The goal is to have a fantastic customer experience where the product gets to them as soon as possible."
The online pharmacy platform offers two-day deliveries to Amazon Prime members. It will also provide 24/7 access to clinical pharmacists to handle customer inquiries about the medications.
"We actually don't think that's a high enough bar. We're still getting started," Amazon Pharmacy Vice President John Love told CNBC about the two-day delivery option.
Love added, "But this is what I think makes us an attractive partner and collaborator for all sorts of folks like Lilly, payers, providers who are looking for a different type of pharmacy."
LillyDirect launched in January, connects people directly with an independent health company which prescribes drugs to eligible customers only, eliminating the need to go to doctor for prescription.
The pharmaceutical giant also has another online delivery partner, Truepill, to deliver medications to patients.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
|
03.12.25 |
Eli Lilly not yet ready to unfreeze UK investments, says pharma boss (Financial Times) | |
|
02.12.25 |
S&P 500-Titel Eli Lilly-Aktie: So viel Gewinn hätte eine Eli Lilly-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
|
28.11.25 |
Freundlicher Handel: S&P 500 zum Handelsende mit Zuschlägen (finanzen.at) | |
|
28.11.25 |
S&P 500-Handel aktuell: S&P 500 steigt nachmittags (finanzen.at) | |
|
28.11.25 |
Freitagshandel in New York: S&P 500 am Mittag freundlich (finanzen.at) | |
|
28.11.25 |
Aufschläge in New York: S&P 500 zum Start mit Zuschlägen (finanzen.at) | |
|
25.11.25 |
S&P 500-Papier Eli Lilly-Aktie: So viel Gewinn hätte ein Investment in Eli Lilly von vor 5 Jahren abgeworfen (finanzen.at) | |
|
21.11.25 |
Eli Lilly-Aktie im Höhenflug: Billionen-Grenze überschritten dank starker Wachstumsziele (dpa-AFX) |
Analysen zu Eli Lillymehr Analysen
| 20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
| Eli Lilly | 852,90 | -2,35% |
|